Why the study?
Does anticoagulation treatment prevent embolic events in patients with left ventricular mural thrombi complicating acute myocardial infarction?
Does anticoagulation treatment prevent embolic events in patients with left ventricular mural thrombi complicating acute myocardial infarction?
Answers are grounded in this paper and cite their sources.
Anticoagulation treatment appears to protect against embolic events in patients with left ventricular mural thrombi following acute myocardial infarction, though it does not affect the persistence of the thrombus.
To determine the clinical significance of left ventricular thrombi, we used two-dimensional echocardiography to study 261 patients with acute transmural myocardial infarction. Mural thrombi were found in 46 patients. This complication occurred in 34% (44 of 130) of anterior wall infarctions but in only 1.5% (2 of 131) of inferior wall infarctions. An apical wall motion abnormality was present in all patients with thrombus. Severe depression of left ventricular function was not a prerequisite for thrombus formation: the mean left ventricular ejection fraction was 37 +/- 1.5%. Forty-three patients with left ventricular thrombi were followed for a mean duration of 15 months with serial echocardiography. None of the 25 patients who received anticoagulation treatment had an embolic event. Embolization occurred in 7 of 18 patients who had not received anticoagulation treatment. All embolic events occurred within 4 months of infarction. Although anticoagulation treatment appeared to provide protection against embolic events, the prevalence of left ventricular thrombi on follow-up echocardiographic study was essentially the same whether or not this treatment was used.
No takes yet. Share an insight, caveat, or question.
David J. Weinreich (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: